ICM
EME icon

Invenomic Capital Management’s Emcor EME Stock Holding History

Invenomic Capital Management’s Portfolio EME Stock Details EME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-31,264
Closed -$3.22M – 161
2022
Q2 		$3.22M Buy
+31,264
New +$3.34M 0.23% 103
2020
Q3 		– Sell
-2,462
Closed -$163K – 151
2020
Q2 		$163K Hold
2,462
– – 0.12% 139
2020
Q1 		$151K Buy
+2,462
New +$190K 0.12% 128

Other funds holding EME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invenomic Capital Management's EME Position: Q3 2022 in Review

Invenomic Capital Management sold out of Emcor (EME) in Q3 2022, closing a stake of 31,264 shares — an estimated $3.22M sold.

Invenomic Capital Management first reported a position in EME in Q1 2020 and held it in 3 quarters. The position peaked at $3.22M in Q2 2022. 383 funds tracked by Wall St. Rank hold EME as of Q3 2022.

  • Invenomic Capital Management reported no remaining Emcor position as of Q3 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 31,264 Emcor shares in Q3 2022, an estimated $3.22M.
  • Invenomic Capital Management first reported a position in Emcor in Q1 2020 and held it in 3 quarters.
  • Invenomic Capital Management's Emcor position peaked at $3.22M in Q2 2022.
  • 383 funds tracked by Wall St. Rank held Emcor as of Q3 2022.

Based on Invenomic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.